|
1
|
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
|
$4.16M
|
–
|
–
|
–
|
|
|
2
|
GMT Capital
Atlanta,
Georgia
|
$3.21M
|
+$884K
|
+74,965
|
+35%
|
|
|
3
|
|
$1.95M
|
+$123K
|
+10,471
|
+6%
|
|
|
4
|
|
$1.84M
|
-$1.76M
|
-148,975
|
-47%
|
|
|
5
|
Renaissance Technologies
New York
|
$1.43M
|
+$659K
|
+55,892
|
+76%
|
|
|
6
|
Acadian Asset Management
Boston,
Massachusetts
|
$1.03M
|
+$206K
|
+17,509
|
+23%
|
|
|
7
|
K2 Principal Fund
Toronto,
Ontario, Canada
|
$1.03M
|
+$1.1M
|
+92,931
|
New
|
|
|
8
|
Vanguard Group
Malvern,
Pennsylvania
|
$939K
|
-$51.7K
|
-4,390
|
-5%
|
|
|
9
|
Aisling Capital Management
New York
|
$929K
|
–
|
–
|
–
|
|
|
10
|
Millennium Management
New York
|
$731K
|
+$265K
|
+22,507
|
+51%
|
|
|
11
|
Farallon Capital Management
San Francisco,
California
|
$681K
|
–
|
–
|
–
|
|
|
12
|
Citadel Advisors
Miami,
Florida
|
$636K
|
+$72.2K
|
+6,121
|
+12%
|
|
|
13
|
MPM BioImpact
Boston,
Massachusetts
|
$596K
|
–
|
–
|
–
|
|
|
14
|
Two Sigma Advisers
New York
|
$523K
|
-$106K
|
-8,984
|
-16%
|
|
|
15
|
RA Capital Management
Boston,
Massachusetts
|
$515K
|
+$550K
|
+46,633
|
New
|
|
|
16
|
|
$492K
|
+$66.2K
|
+5,618
|
+14%
|
|
|
17
|
Two Sigma Investments
New York
|
$436K
|
-$195K
|
-16,566
|
-30%
|
|
|
18
|
|
$413K
|
-$31.8K
|
-2,700
|
-7%
|
|
|
19
|
Geode Capital Management
Boston,
Massachusetts
|
$355K
|
-$352K
|
-29,902
|
-48%
|
|
|
20
|
GSA Capital Partners
London,
United Kingdom
|
$304K
|
-$8K
|
-679
|
-2%
|
|
|
21
|
New Leaf Venture Partners
New York
|
$290K
|
–
|
–
|
–
|
|
|
22
|
|
$136K
|
-$121K
|
-10,275
|
-45%
|
|
|
23
|
State Street
Boston,
Massachusetts
|
$130K
|
-$476K
|
-40,413
|
-77%
|
|
|
24
|
|
$128K
|
+$137K
|
+11,587
|
New
|
|
|
25
|
Bridgeway Capital Management
Houston,
Texas
|
$124K
|
-$96.4K
|
-8,175
|
-42%
|
|
